Bridging Data to Discovery

Next-Gen Flow Cytometry
Biomarker Discovery

Integrity | Expertise | Collaboration

  • Who We Are

    Our team brings decades of experience in high-parameter flow cytometry, machine learning, and translational research, spanning preclinical drug development, clinical trials, and beyond. We know firsthand how AI is about to transform biomarker discovery, and we’re here to help you lead the way.

  • What We Do

    By setting new benchmarks in data quality and standardization, Interro IQ is shaping the future of precision medicine. We drive groundbreaking therapeutic innovations using advanced analytics and high-fidelity biological insights.

  • What We Believe

    The future of scientific discovery depends on data integrity, transparency, and rigor. In an era where AI-driven research is accelerating breakthroughs, the foundation of every innovation must be built on uncompromising scientific standards.

At Interro IQ, we know:

  • High-integrity data leads to high-impact discoveries.

  • Standardization isn’t a limitation, it’s a launchpad for innovation.

  • AI and machine learning are only as powerful as the quality of the data they rely on.

We are Committed

We are committed
to ensuring biomarker discovery is driven by precision, reproducibility, and scientific excellence. We know enabling AI into your flow cytometry biomarker discovery is about intelligently structured data founded on known biology.

At Interro IQ, we are developing a universal, disease-agnostic immunophenotyping platform—a system designed to standardize and optimize flow cytometry data for the AI-driven discoveries ahead.

Because the future of biomarker discovery shouldn’t be guesswork, it should be groundbreaking.

OUR MISSION

At Interro IQ, we empower clinicians and scientists who work tirelessly to decode the complexities of human pathophysiology. We provide innovative, reliable solutions that support breakthrough research and enable optimal care.

OUR VISION

We envision a future where flow cytometry transforms personalized medicine. By turning diverse, variable data into a standardized, disease-agnostic repository, we are laying the groundwork for next-generation AI/ML discoveries. Rooted in over 40 years of scientific innovation and commitment to the highest standards of integrity, our universal immunophenotyping screen will accelerate therapeutic advancements and set new benchmarks for optimal care.